| View |
|
DRP-9641
|
Salbutamol (as sulfate) + Guaifenesin + Bromhexine Hydrochloride
|
Ventuss Plus
|
1 mg/ 50 mg/ 2 mg per 5 mL
|
Syrup (Mint Flavor)
|
Selective beta-2-adrenoreceptor agonist/ Expectorant/ Mucolytic
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
Initial
|
22 April 2021
|
22 April 2026
|
| View |
|
DR-XY47239
|
Co-Trimoxazole
|
Trimozol
|
480mg / 5 mL
|
Solution for Intravenous Infusion
|
Antibacterial
|
Swiss Pharmaceutical Co., Ltd. (Xinshi Plant)
|
Taiwan
|
Initial
|
22 April 2021
|
22 April 2026
|
| View |
|
DRP-9661
|
Moxifloxacin (as hydrochloride)
|
Lumemox
|
5 mg/mL (0.5% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Anti-infective (Fluoroquinolone)
|
Axa Parenterals Limited
|
India
|
Initial (Reconstruction)
|
12 August 2024
|
23 April 2026
|
| View |
|
DR-XY47243
|
Gentamicin (as Sulfate)
|
Gxacin
|
3 mg/mL (0.3% w/v)
|
Sterile Ophthalmic Solution
|
Antibacterial (Aminoglycoside)
|
Axa Parenterals Limited
|
India
|
Initial
|
23 April 2021
|
23 April 2026
|
| View |
|
DRP-9662
|
Ascorbic Acid + Zinc
|
PAKZNC
|
500mg (equivalent to 562.5mg Sodium Ascorbate) / 40mg (equivalent to 109.8mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin/ Mineral
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
23 April 2021
|
23 April 2026
|
| View |
|
DR-XY47244
|
Betamethasone Dipropionate
|
Betady
|
500 mcg per gram (0.05% w/w)
|
Topical Cream
|
Corticosteroid
|
Front Pharmaceutical PLC
|
China
|
Initial
|
23 April 2021
|
23 April 2026
|
| View |
|
DR-XY47237
|
Lamivudine
|
Lavudine
|
100 mg
|
Film Coated Tablet
|
Antiviral
|
Standard Chem. & Pharm. Co., Ltd. (Plant II)
|
Taiwan
|
Initial
|
23 April 2021
|
23 April 2026
|
| View |
|
DR-XY47245
|
Nifedipine
|
Adapine S.R.F.C
|
30 mg
|
Sustained Release Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Standard Chem. & Pharm. Co., Ltd.
|
Taiwan
|
Initial
|
26 April 2021
|
26 April 2026
|
| View |
|
DR-XY47246
|
Rosuvastatin (As Calcium)
|
Rostan
|
10 mg
|
Film Coated Tablet
|
Lipid Modifying Agent (HMG COA Reductase Inhibitor)
|
Standard Chem. & Pharm. Co., Ltd. (Plant II)
|
Taiwan
|
Initial
|
26 April 2021
|
26 April 2026
|
| View |
|
DRP-9652
|
Omeprazole
|
Gastome
|
20mg
|
Delayed-Release Capsule
|
Proton pump inhibitor
|
Zim Laboratories Ltd.
|
India
|
Initial
|
26 April 2021
|
26 April 2026
|
| View |
|
DR-XY47241
|
Omeprazole
|
None
|
20mg
|
Delayed-Release Capsule
|
Proton pump inhibitor
|
Zim Laboratories Ltd.
|
India
|
Initial
|
26 April 2021
|
26 April 2026
|
| View |
|
DR-XY47242
|
Omeprazole
|
None
|
20mg
|
Delayed-Release Capsule
|
Proton pump inhibitor
|
Zim Laboratories Ltd.
|
India
|
Initial
|
26 April 2021
|
26 April 2026
|
| View |
|
DRP-9667
|
Clonidine Hydrochloride
|
None
|
150mcg
|
Tablet
|
Antihypertensive (Imidazole receptor agonist)
|
AM-Europharma Corporation
|
Philippines
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9660
|
Zoledronic Acid
|
Zdonate
|
5mg/100mL
|
Solution for Injection (I.V. Infusion)
|
Bisphosphonate
|
Gland Pharma Limited
|
India
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9664
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Pitanic
|
4 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9666
|
Olanzapine
|
Olan ODT
|
10 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Micro Labs Limited
|
India
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9668
|
Ceftriaxone (As Sodium)
|
Synoxon
|
1 g
|
Powder For Injection(IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company
Limited
|
China
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9663
|
Cholecalciferol (Vitamin D3) + Minerals
|
Calcidoc Plus
|
Each film-coated tablet contains: Cholecalciferol (Vitamin D3), USP-500IU Calcium (equivalent to 1498.38mg Calcium Carbonate), USP-600mg Magnesium (equivalent to 82.92mg Magnesium Oxide), USP-50mg
Zinc (equivalent to 9.34mg Zinc Oxide), USP-7.5mg Manganese (equivalent to 5.54mg Manganese Sulfate Monohydrate), USP-1.8mg Copper (equivalent to 3.93mg Copper Sulfate Pentahydrate), USP-1mg
|
Film Coated Tablet
|
Vitamin / Minerals
|
Phil. United Pharma Corp.(PUPC)
|
Philippines
|
Initial (OTC)
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9674
|
Ascorbic Acid
|
None
|
500mg (equivalent to 562.43 mg Sodium Ascorbate) /10mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin/Mineral
|
Philmed Laboratories, Inc.
|
Philippines
|
Initial (OTC)(PCPR)
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9676
|
Ascorbic Acid + Zinc
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/ 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin/ Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial (OTC)(PCPR)
|
28 April 2021
|
28 April 2026
|